James A. Bianco

CIK 1198554 · Chief Executive Officer · last filed 2026-05-29

James A. Bianco is a Chief Executive Officer who has filed 94 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing, for HURA, was dated May 29, 2026. Across all open-market trades the lifetime net is −$9.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $5.0M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$5.04M

Companies

3

Total Filings

94

Lifetime Open-Market Net

-$9.03M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
HURA Chief Executive Officer 2,173,307 $2.32 $5.04M $0 5 2026-05-29
CTI BIOPHARMA CORP (CTIC) Delisted President and CEO 1,780,133 $9.09 $16.18M -$1.62M 18 2016-10-03
CTI BIOPHARMA CORP (TRGT) Delisted President and CEO 3,489,118 -$7.41M 71 2015-03-24

Recent Filings

94 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2026-05-29 HURA Gift (G) −150,000 $0 EDGAR
2026-01-08 HURA Grant (A) $0 EDGAR
2025-12-17 HURA Grant (A) $0 EDGAR
2024-11-14 HURA Grant (A) $0 EDGAR
2024-10-22 HURA Grant (A) +2,323,307 $0 EDGAR
2016-10-03 CTI BIOPHARMA CORP (CTIC) Delisted Grant (A) $0 EDGAR
2016-06-24 CTI BIOPHARMA CORP (CTIC) Delisted Sell (S) −10,000 -$3.7K EDGAR
2016-05-27 CTI BIOPHARMA CORP (CTIC) Delisted Sell (S) −10,000 -$4.5K EDGAR
2016-05-20 CTI BIOPHARMA CORP (CTIC) Delisted Grant (A) $0 EDGAR
2016-04-29 CTI BIOPHARMA CORP (CTIC) Delisted Sell (S) −10,000 -$5.2K EDGAR
Showing 110 of 94
Page 1 of 10
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.